CEO | Founder | Philanthropist
Interview Series - Greg Brady, Founder and CEO of Connect4Patients
In this in-depth interview with Unite.AI, Greg Brady shares how his experience designing one of the world’s first large-scale multi-enterprise supply chain networks directly influenced his approach to solving some of healthcare’s most persistent data and interoperability challenges. Drawing from his leadership at One Network Enterprises, Brady explains why fragmented systems, disconnected records, and the absence of a single version of truth continue to create inefficiencies, administrative burden, rising costs, and preventable medical errors across the healthcare industry.
The discussion explores how Connect4Patients and The Healthcare Network were designed to create a secure, patient-centric infrastructure that unifies healthcare data across hospitals, physicians, laboratories, insurers, and patients. Brady outlines how AI-powered systems can help cleanse and organize fragmented records, support more informed clinical decision-making, reduce risks of drug interactions, and improve patient understanding through clearer, more accessible health information.
Mr. Brady also discusses why previous interoperability initiatives struggled to achieve widespread success and explains how a many-to-many network model could simplify integration while improving scalability and security across the healthcare ecosystem. Throughout the interview, he emphasizes that AI alone cannot transform healthcare without a reliable, complete, and continuously updated data foundation that supports preventive care, personalized medicine, and more proactive long-term health management.
The conversation further examines the role of patient-controlled permissions, HIPAA-compliant infrastructure, wellness data integration, and AI learning models in creating a more connected and prevention-focused healthcare system. Greg Brady argues that placing patients at the center of the healthcare experience, while enabling secure collaboration among providers, could significantly improve outcomes, lower costs, and reduce avoidable harm over the coming decade.